ORIX Growth Capital recently made a $20 million growth capital investment in Infusionsoft, an industry-leading customer relationship management (CRM) provider for small businesses, with 180,000 users worldwide. Earlier this year the company revealed plans for market expansion with the launch of a new, easier-to-use CRM built specifically for small business service providers with lower pricing and a free trial. The investment from ORIX Growth Capital will help Infusionsoft accelerate product development, branding and marketing of its new, simple CRM for small businesses.
“We are excited to partner with Infusionsoft given their expertise in small business and long track record as an industry-leading CRM provider,” said Jon Weitzel, Director at ORIX Growth Capital. “Implementing and managing separate, stand-alone CRMs, email marketing, sales automation and e-commerce software is complex and creates manual work for small businesses using multiple systems. Infusionsoft’s new CRM enables small businesses to have customer information and daily work in one place, eliminating the repetitive tasks that take time and focus away from delivering great service.”
During two years of intensive customer and market research, Infusionsoft found 70 percent of small businesses think customers are more demanding today than in the past. According to this research, 70 percent of small businesses also want to quit the hodgepodge of tools they use to manage customer relationships.
“Infusionsoft has been empowering small businesses to deliver great service for many years,” said Clate Mask, CEO of Infusionsoft. “We’ve watched small businesses struggle to keep up with customer demands, and the hodgepodge of apps and systems that should make it easier, often create more work and stress. For a long time, we didn’t have a simple CRM to serve the needs of the broader market, but we do now. We are excited to partner with ORIX to bring millions of small businesses the peace of mind that comes with knowing you’re delivering consistently great service.”